Mitchell Mcleod Pugh & Williams Inc. Reduces Position in Clorox Co (CLX)
Mitchell Mcleod Pugh & Williams Inc. lessened its holdings in shares of Clorox Co (NYSE:CLX) by 9.4% in the 1st quarter, HoldingsChannel reports. The fund owned 5,954 shares of the company’s stock after selling 620 shares during the quarter. Mitchell Mcleod Pugh & Williams Inc.’s holdings in Clorox were worth $955,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Webster Bank N. A. boosted its holdings in Clorox by 5.6% in the 1st quarter. Webster Bank N. A. now owns 19,920 shares of the company’s stock valued at $3,197,000 after purchasing an additional 1,052 shares during the last quarter. Old North State Trust LLC boosted its holdings in Clorox by 6.6% in the 1st quarter. Old North State Trust LLC now owns 1,870 shares of the company’s stock valued at $300,000 after purchasing an additional 115 shares during the last quarter. Pacer Advisors Inc. acquired a new position in Clorox in the 1st quarter valued at about $1,966,000. Manning & Napier Group LLC lifted its holdings in shares of Clorox by 29.0% in the 1st quarter. Manning & Napier Group LLC now owns 60,684 shares of the company’s stock worth $9,736,000 after acquiring an additional 13,627 shares during the last quarter. Finally, TrimTabs Asset Management LLC lifted its holdings in shares of Clorox by 5.0% in the 1st quarter. TrimTabs Asset Management LLC now owns 9,457 shares of the company’s stock worth $1,517,000 after acquiring an additional 448 shares during the last quarter. 76.89% of the stock is owned by institutional investors.
Shares of NYSE:CLX traded up $1.74 during trading hours on Thursday, reaching $155.53. The stock had a trading volume of 17,690 shares, compared to its average volume of 911,688. Clorox Co has a 1 year low of $113.57 and a 1 year high of $167.70. The company has a current ratio of 1.15, a quick ratio of 0.66 and a debt-to-equity ratio of 3.08. The company has a market cap of $19.71 billion, a PE ratio of 24.84, a P/E/G ratio of 3.80 and a beta of 0.32.
The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be given a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.47%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 61.34%.
CLX has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Clorox from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a report on Monday, March 11th. BMO Capital Markets set a $175.00 price objective on shares of Clorox and gave the stock a “buy” rating in a report on Tuesday, February 5th. Wells Fargo & Co restated a “hold” rating and issued a $157.00 price objective on shares of Clorox in a report on Monday, February 4th. Barclays restated a “hold” rating and issued a $142.00 price objective on shares of Clorox in a report on Wednesday, February 6th. Finally, Citigroup set a $171.00 price objective on shares of Clorox and gave the stock a “hold” rating in a report on Tuesday, February 5th. Six research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and an average price target of $151.21.
In related news, SVP Andrew J. Mowery sold 5,340 shares of the stock in a transaction on Friday, March 1st. The shares were sold at an average price of $156.44, for a total value of $835,389.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Matthew T. Laszlo sold 10,585 shares of the stock in a transaction on Wednesday, February 6th. The shares were sold at an average price of $153.89, for a total transaction of $1,628,925.65. Following the completion of the transaction, the senior vice president now directly owns 17,994 shares in the company, valued at $2,769,096.66. The disclosure for this sale can be found here. Company insiders own 1.40% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Index Funds
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.